RNF40 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.405000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.559000E-01
Normal-vs-Stage2
4.286800E-01
Normal-vs-Stage3
5.023400E-01
Normal-vs-Stage4
2.592300E-02
Stage1-vs-Stage2
9.500300E-02
Stage1-vs-Stage3
3.214400E-01
Stage1-vs-Stage4
2.726100E-02
Stage2-vs-Stage3
5.770000E-02
Stage2-vs-Stage4
6.172800E-01
Stage3-vs-Stage4
9.116200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.790200E-01
Normal-vs-AfricanAmerican
3.033200E-01
Normal-vs-Asian
4.177600E-01
Caucasian-vs-AfricanAmerican
1.857040E-01
Caucasian-vs-Asian
8.209200E-01
AfricanAmerican-vs-Asian
4.113400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.124800E-01
Normal-vs-Female
4.900400E-01
Male-vs-Female
8.253400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.080400E-01
Normal-vs-Age(41-60Yrs)
1.583570E-01
Normal-vs-Age(61-80Yrs)
5.943200E-01
Normal-vs-Age(81-100Yrs)
4.174000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.358200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.798600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.142200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.761800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.065200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.141200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.495600E-01
Normal-vs-Daily Drinker
5.717800E-01
Normal-vs-Weekly Drinker
3.943000E-01
Normal-vs-Occasional Drinker
2.229800E-01
Normal-vs-Social Drinker
9.032100E-02
Non Drinker-vs-Daily Drinker
2.331000E-01
Non Drinker-vs-Weekly Drinker
1.400380E-01
Non Drinker-vs-Occasional Drinker
4.305700E-02
Non Drinker-vs-Social Drinker
1.322050E-02
Daily Drinker-vs-Weekly Drinker
7.688200E-01
Daily Drinker-vs-Occasional Drinker
5.343000E-01
Daily Drinker-vs-Social Drinker
2.866400E-01
Weekly Drinker-vs-Occasional Drinker
7.698400E-01
Weekly Drinker-vs-Social Drinker
4.235200E-01
Occasional Drinker-vs-Social Drinker
5.453800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.738000E-01
Normal-vs-Grade 2
6.900800E-01
Normal-vs-Grade 3
6.308200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.998000E-02
Grade 1-vs-Grade 3
6.277100E-03
Grade 1-vs-Grade 4
7.738000E-01
Grade 2-vs-Grade 3
7.804100E-02
Grade 2-vs-Grade 4
6.900800E-01
Grade 3-vs-Grade 4
6.308200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.816400E-01
Normal-vs-NonDiabetic
3.625000E-01
Diabetic-vs-NonDiabetic
9.624500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.677900E-02
Normal-vs-NoPancreatitis
5.072400E-01
Pancreatitis-vs-NoPancreatitis
2.878500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.513800E-01
Normal-vs-N1
4.520000E-01
N0-vs-N1
6.589000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.058200E-01
Normal-vs-TP53-NonMutant
8.468400E-01
TP53-Mutant-vs-TP53-NonMutant
6.403000E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
